Oxidative damage to DNA in plaques of MS brains

Multiple Sclerosis

Volumn 4, Issue 5, 1998, Pages 413-418

  Vladimirova, Olga ^a   O'Connor, John ^b   Cahill, Alan ^c   Alder, Hansjuerg ^d   Butunoi, Catalin ^e   Kalman, Bernadette ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

^e Rocky Mountain MS Center   (United States)

Author keywords

Clinical disability; Oxidative damage; Plaque

Indexed keywords

DNA; GUANOSINE DERIVATIVE; MARKER;

ADOLESCENT; ADULT; ARTICLE; CEREBELLUM CORTEX; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DAMAGE; ENCEPHALITIS; HUMAN; HUMAN TISSUE; HYPOTHESIS; MULTIPLE SCLEROSIS; OXIDATION; WHITE MATTER;

EID: 0031766122     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1191/135245898678919456     Document Type: Article

References (41)

1. Prineas JW et al. (1993) Multiple sclerosis: Remyelination of nascent lesions. Ann Neurol 33: 137-151.
2. Ozawa K et al. (1994) Patterns of oligodendroglia pathology in multiple sclerosis. Brain 117: 1311-1322.
3. Raine CS, Scheinberg LC, Waltz JM. (1981) Multiple sclerosis: oligodendrocyte survival and proliferation in an active, established lesion. Lab Invest 45: 534-546.
4. Wu E, Raine CS. (1992) Multiple sclerosis: Interaction between oligodendrocytes and hypertrophic astrocytes and their occurrence in other, nondemyelinating conditions. Lab Invest 67: 88-99.
5. Bruck W et al. (1994) Oligodendrocytes in the early course of multiple sclerosis. Ann Neurol 35: 65-73.
6. Barnes D et al. (1991) The longstanding MS lesion. A quantitative MRI and electron microscopic study. Brain 114: 1271-1280.
7. De Stefano N et al. (1995) Chemical pathology of acute demyelinating lesions and its correlation with disability. Ann Neurol 38: 901-909.
8. Davie CA et al. (1995) Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axonal loss. Brain 118: 1583-1592.
9. 1H spectroscopic imaging. Ann Neurol 36: 157-165.
10. Mecocci P, MacGarvey U, Beal F. (1994) Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann Neurol 36: 747-751.
11. Browne SE et al. (1997) Oxidative damage and metabolic dysfunction in Huntington's disease: Selective vulner-ability of the basal ganglia. Ann Neurol 41: 646-653.
12. Mecocci P et al. (1993) Oxidative damage to mitochondrial DNA shows marked age dependent increase in human brain. Ann Neurol 34: 609-616.
13. Vachier I et al. (1994) Imaging reactice oxygen species in asthma. J Bioluminescence and Chemiluminescence 9: 171-175.
14. Armstrong D, Al-Awadi F. (1991) Lipid peroxidation and retinopathy in streptozocininduced diabetes. Free Radic Biol Med 11: 433-436.
15. Dandona P et al. (1996) Oxidative damage to DNA in diabetes mellitus. Lancet 347: 444-445.
16. Richter C et al. (1995) Oxidants in mitochondria: from physiology to diseases. Biochim Biophys Acta 1271: 67-74.
17. Richter C, Park J-W, Ames BN. (1988) Normal oxidative damage to mitochondrial and nuclear DNA is extensive. Proc Natl Acad Sci 85: 6465-6467.
18. Bo L et al. (1994) Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains. Ann Neurol 36: 778-786.
19. Bagasra O et al. (1995) Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis. Proc Natl Acad Sci 92: 12041-12045.
20. Merril JE et al. (1993) Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J Immunol 151: 2132-2141.
21. Liu RH, Hotchkiss JH. (1995). Potential genotoxicity of chronically elevated nitric oxide: a review. Mutation Res 339: 73-89.
22. Beck J et al. (1988) Increased production of interferon-gamma and tumor necrosis precedes clinical manifestation in multiple sclerosis. Acta Neurol Scand 78: 318-323.
23. Chofflon M et al. (1992) Tumor necrosis factor alpha production as a possible predictor of relapse in patients with multiple sclerosis. Eur Cytokine Netw 3: 523-531.
24. Selmaj K, Raine CS, Gannella B, Brosnan CF. (1991) Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions J Clin Invest 87: 949-954.
25. Selmaj K, Raine CS. (1988) Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol 23: 339-346.
26. Ames BN, Shigenaga MK, Hagen TM. (1995) Mitochondrial decay in aging. Biochim Biophys Acta 1271: 165-170.
27. Schapira AHV et al. (1990) Mitochondrial Complex I deficiency in Parkinson's disease. J Neurochem 54: 823-827.
28. Schapira AHV et al. (1990) Anatomic and disease specificity of NADH CoQ1 reductase (Complex I) deficiency in Parkinson's disease. J Neurochem 55: 2142-2145.
29. Beal MF. (1992) Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illness? Ann Neurol 31: 119-130.
30. Davis RE et al. (1997) Mutations in mitochondrial cytochrome c oxidase genes segregate with late-onset Alzheimer disease. Proc Natl Acad Sci 94: 4526-4531.
31. Filippi M et al. (1995) A magnetization transfer imaging study of normal-appearing white matter in multiple sclerosis. Neurology 45: 478-482.
32. Brett R, Rumsby MG. (1993) Evidence of free radical damage in the central nervous system of guinea-pigs at the prolonged acute and early relapse stages of chronic relapsing experimental allergic encephalomyelitis. Neurochem. Int 23: 35-44.
33. Ruuls SR et al. (1995) Reactive oxygen species are involved in the pathogenesis of experimental allergic encephalomyelitis in Lewis rats. J Neuroimmunol 56: 207-217.
34. MacMicking JD et al. (1992) Elevated secration of reactive nitrogen and oxygen intermediates by inflammatory leukocytes in hyperacute experimental autoimmune encephalomyelitis: Enhancement by the soluble products of encephalitogenic T cells. J Exp Med 176: 303-307.
35. Fisher M et al. (1988) Monocyte and polymorphonuclear leukocyte toxic oxygen metabolite production in multiple sclerosis. Inflammation 12: 123-131.
36. Hammann KP, Hopf HC. (1986). Monocyte constitute the only peripheral blood cell population showing an increased burst activity in multiple sclerosis patients. Int Archs Allergy Appl Immun 81: 230-234.
37. Konat GW, Wiggins RC. (1985) Effect of reactive oxygen species on myelin membrane proteins. J Neurochem 45: 1113-1118.
38. Kim YS, Kim SU. (1991) Oligodendroglial cell death induced by oxygen radicals and its protection by catalase. J Neurosci 29: 100-106.
39. Bruck W et al. (1997) Inflammatory central nervous system demyelination: Correlation of magnetic resonance imaging findings with lesion pathology. Ann Neurol 42: 783-793.
40. Powell T, Sussman JG, Davies-Jones GAB. (1992) MR imaging in acute multiple sclerosis: Ringlike appearance in plaques suggesting the presence of paramagnetic freeradicals. AJNR 13: 1544-1546.
41. Croteau DL et al. (1997) An oxidative damage-specific endonuclease from rat liver mitochondria. J Biol Chem 272: 27338-27344.